Zobrazeno 1 - 10
of 121
pro vyhledávání: '"halobetasol propionate"'
Publikováno v:
JAAD International, Vol 6, Iss , Pp 13-19 (2022)
Background: The effects of halobetasol propionate (HBP) lotion 0.05% on the hypothalamic-pituitary-adrenal (HPA) axis have not been previously evaluated in adolescents. Objective: To examine the effect of HBP on HPA axis suppression in patients aged
Externí odkaz:
https://doaj.org/article/9b2fd133847845d3a895f520e3ec634f
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 13, Pp 391-398 (2020)
Vidhatha Reddy,1 Bridget Myers,1 Eric J Yang,2 Tina Bhutani1 1University of California, San Francisco, Department of Dermatology, San Francisco, CA, USA; 2Virginia Mason Medical Center, Seattle, WA, USACorrespondence: Vidhatha ReddyUniversity of Cali
Externí odkaz:
https://doaj.org/article/76950fec903043058e5584888aa0df7a
Autor:
Linda Stein Gold, Abby Jacobson, James Q Del Rosso, Nelly K Gilyadov, Mark Lebwohl, Emil Tanghetti
Publikováno v:
Dermatology and Therapy
Psoriasis is a lifelong disease associated with cycles of remission and relapse. Topical treatments are the front line of psoriasis therapy for most patients and have antiproliferative, anti-inflammatory, and immunosuppressive mechanisms of action. N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3c82b357646b0ca11c88b68ba72e18
https://doi.org/10.1007/s13555-021-00560-6
https://doi.org/10.1007/s13555-021-00560-6
Publikováno v:
Journal of Dermatological Treatment. 33:2068-2074
Background The topical corticosteroid halobetasol propionate (HP) and retinoid tazarotene (TAZ) are effective in psoriasis treatment. Fixed-combination HP 0.01%/TAZ 0.045% lotion has demonstrated efficacy and safety in moderate-to-severe plaque psori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c734469caa58719453bbc00268342ee0
https://doi.org/10.1080/09546634.2021.1914310
https://doi.org/10.1080/09546634.2021.1914310
Publikováno v:
JAAD International
JAAD International, Vol 6, Iss, Pp 13-19 (2022)
JAAD International, Vol 6, Iss, Pp 13-19 (2022)
Background: The effects of halobetasol propionate (HBP) lotion 0.05% on the hypothalamic-pituitary-adrenal (HPA) axis have not been previously evaluated in adolescents. Objective: To examine the effect of HBP on HPA axis suppression in patients aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b54bac107c6d89ed7973f987bbb9a7
https://pubmed.ncbi.nlm.nih.gov/34870246
https://pubmed.ncbi.nlm.nih.gov/34870246
Publikováno v:
Journal of Drugs in Dermatology. 20:252-258
Background Psoriasis is a chronic, inflammatory disease that may differ in prevalence and clinical presentation among patients from various racial and ethnic groups. Two phase 3 studies demonstrated efficacy and safety of halobetasol propionate (HP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9c292d13e835eb9be7858d3ec16678
https://doi.org/10.36849/jdd.5698
https://doi.org/10.36849/jdd.5698
Publikováno v:
Current Dermatology Reports. 10:21-25
This article reviews in detail the merits and unique nature of this combination lotion and also discusses a new type of strategy for treating psoriasis topically. The combination lotion proved much more efficacious than the vehicle. Moreover, when th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5f207b0c2d2de6ffcd8ca482c2d8d6d
https://doi.org/10.1007/s13671-020-00327-w
https://doi.org/10.1007/s13671-020-00327-w
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 5:164-167
Background: Psoriasis is a chronic inflammatory disease that affects skin and joints and is associated with numerous comorbidities. There are several clinical subtypes including the uncommon pustular variants, which are subdivided into generalized an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94684a4721b21ed2eb9f1025f6cd298e
https://doi.org/10.1177/2475530320950290
https://doi.org/10.1177/2475530320950290
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology. 13:391-398
Halobetasol propionate and tazarotene lotion 0.01%/0.045% (HP/TAZ) is a topical medication approved for the treatment of plaque psoriasis in adults. As a treatment modality, HP/TAZ has a combinatory therapeutic effect because it contains both a corti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7755c3c59725dadb3aff179cf620f7
https://doi.org/10.2147/ccid.s252426
https://doi.org/10.2147/ccid.s252426
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.